Department of Neurology, Faculty of Medicine, Mashhad University of Medical Sciences, Quaem Medical Center, Mashhad, Iran.
Department of Psychiatry, Faculty of Medicine, Mashhad University of Medical Sciences, Psychiatry and Behavioral Sciences Research Center, Ibn-Sina Medical Center, Mashhad, Iran.
Brain Stimul. 2020 Jan-Feb;13(1):190-196. doi: 10.1016/j.brs.2019.10.003. Epub 2019 Oct 7.
BACKGROUND: There is controversial evidence about the effect of cerebellar low-frequency stimulation in patients with essential tremor (ET). OBJECTIVES: In this study we assessed safety and effectiveness of 1 Hz (low-frequency) cerebellar repetitive transcranial magnetic stimulation (rTMS) on tremor severity in patients with essential tremor in a sham-controlled crossover trial. METHODS: A total of 23 patients assigned into two groups to receive either sham (n = 10) or rTMS (n = 13) treatment, with crossing over after a two-month washout period. Intervention consisted of 900 pulses of 1 Hz rTMS at 90% resting motor threshold or the same protocol of sham stimulation over each cerebellar hemisphere for 5 consecutive days. Tremor severity was assessed by Fahn-Tolosa-Marin (FTM) scale at baseline and at days 5, 12 and 30 after intervention. The FTM consists of 3 subscales including tremor severity rating, performance of motor tasks, and functional disability. Carry-over and treatment effects were analyzed using independent samples t-test. RESULTS: There was no significant improvement in the total FTM scores in rTMS compared to the sham stimulation on day 5 (p = 0.132), day 12 (p = 0.574), or day 30 (p = 0.382). Similarly, FTM subscales, including tremor severity rating, motor tasks, and functional disability did not improve significantly after rTMS treatment. Mild headache and local pain were the most frequent adverse events. CONCLUSION: Although cerebellar rTMS seems to have acceptable safety when used in ET patients, this study could not prove any efficacy for it in reduction of tremor in these patients. Larger studies are needed to evaluate efficacy of this therapeutic intervention and to provide evidence about the optimal stimulation parameters.
背景:小脑低频刺激对特发性震颤(ET)患者的疗效存在争议。
目的:本研究采用假刺激对照交叉试验,评估 1Hz(低频)小脑重复经颅磁刺激(rTMS)对特发性震颤患者震颤严重程度的安全性和有效性。
方法:共 23 例患者分为两组,分别接受假刺激(n=10)或 rTMS(n=13)治疗,在 2 个月洗脱期后交叉。干预措施包括 90%静息运动阈值的 1Hz rTMS 900 个脉冲,或每个小脑半球连续 5 天进行相同方案的假刺激。在干预前、干预后第 5、12 和 30 天,采用 Fahn-Tolosa-Marin(FTM)量表评估震颤严重程度。FTM 包括震颤严重程度评分、运动任务表现和功能障碍 3 个亚量表。采用独立样本 t 检验分析交叉和治疗效果。
结果:与假刺激相比,rTMS 在干预后第 5 天(p=0.132)、第 12 天(p=0.574)和第 30 天(p=0.382)时,FTM 总分无显著改善。同样,rTMS 治疗后,震颤严重程度评分、运动任务和功能障碍等 FTM 亚量表也无明显改善。最常见的不良事件是轻度头痛和局部疼痛。
结论:虽然小脑 rTMS 似乎对 ET 患者具有可接受的安全性,但本研究未能证明其对降低这些患者的震颤有任何疗效。需要更大规模的研究来评估这种治疗干预的疗效,并提供关于最佳刺激参数的证据。
Parkinsonism Relat Disord. 2019-3-24
Cureus. 2024-5-1